EX-99.1 2 tm219479d1_ex99-1.htm EXHIBIT 99.1

Exhibit 99.1

JOINT FILING AGREEMENT

In accordance with Rule 13d-1(k), as promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the ordinary shares of Five Prime Therapeutics, Inc., and further agree that this Joint Filing Agreement be included as an Exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this Joint Filing Agreement as of March 15, 2021.

Dated: March 15, 2021

	magnetar financial llc

	By: Magnetar Capital Partners LP, its Sole Member

By:

/s/ Alec N. Litowitz

		Name:	Alec N. Litowitz
		Title:	Manager of Supernova Management LLC, the General Partner of Magnetar Capital Partners LP

magnetar capital partners LP

By:

/s/ Alec N. Litowitz

Name:

Alec N. Litowitz

Title:

Manager of Supernova Management LLC, the General Partner of Magnetar Capital Partners LP

	supernova management llc


	By:	/s/ Alec N. Litowitz

Name:

Alec N. Litowitz

Title:

Manager

	/s/ Alec N. Litowitz
	Alec N. Litowitz

FIVE PRIME THERAPEUTICS, INC. SC 13D